North America Cartilage Degeneration Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Procedure Type (Osteochondral Transplant, Chondroplasty, Joint Replacement, Meniscus Transplants, Cell-based Cartilage Resurfacing, and Others); Application (Knee, Hips and Others); and End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers and Academic & Research Institutes) and Country

Market Introduction

Degeneration of cartilage leads to pain and chronic inflammation in joints of a human body. Furthermore, damaged cartilage can potentially influence the quality of a patient’s life. Continuous research and developments are innovating new techniques and methodologies to deal with damaged cartilages. A few of these techniques comprise joint replacement, cell therapies, and chondroplasty.

Market Overview and Dynamics

The North America cartilage degeneration market is expected to reach US$ 6,998.45 million by 2027 from US$ 4,889.27 million in 2019; it is anticipated to grow at a CAGR of 4.7% from 2020 to 2027. The increasing prevalence of sports injuries and obesity is expected to boost the growth of the cartilage degeneration market in North America. However, the market is impacted by the high cost of cartilage therapies.

Key Market Segments

In terms of procedure type, the joint replacement segment accounted for the largest share of the North America cartilage degeneration market in 2019. In terms of application, the knee segment accounted for the largest share of the North America cartilage degeneration market in 2019. In terms of end user, the hospitals & specialty clinics segment accounted for the largest share of the North America cartilage degeneration market in 2019.

Major Sources and Companies Listed

Major primary and secondary sources associated with the North America cartilage degeneration market report are the World Health Organization (WHO), American Academy of Orthopaedic Surgeons (AAOS), Washington University Orthopedics, Agency for Healthcare Research and Quality, Centers of Disease Control and Prevention (CDC), National Federation of State High School Associations (NFHS), Arthritis Foundation 2020, and others.

Reasons to buy report

• Understand the Northe America cartilage degeneration market landscape and identify cartilage degeneration segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape in the region
• Efficiently plan mergers and acquisitions, and partnership deals in the North America cartilage degeneration market by identifying segments with the most promising probable sales
• Take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments
• Obtain revenue forecast of market based on various segments for the period 2019–2027.

North America cartilage degeneration market segmentation

By Procedure Type

• Joint Replacement
• Chondroplasty
• Cell-based Cartilage Resurfacing
• Osteochondral Transplant
• Meniscus Transplants
• Others

By Application

• Knee
• Hips
• Others

By End User

• Hospitals & Specialty Clinics
• Ambulatory Surgical Centers
• Academic & Research Institutes

By Country

• US
• Canada
• Mexico

Company Profiles

• Zimmer Biomet
• Stryker Corporation
• Johnson and Johnson Services, Inc.
• CONMED Corporation
• Arthrex, Inc.
• Anika Therapeutics, Inc.

The List of Companies - North America Cartilage Degeneration Market

1. Zimmer Biomet
2. Stryker Corporation
3. Johnson and Johnson Services, Inc.
4. CONMED Corporation
5. Arthrex, Inc.
6. Anika Therapeutics, Inc.

• Understand the Northe America cartilage degeneration market landscape and identify cartilage degeneration segments that are most likely to guarantee a strong return.

• Stay ahead of the race by comprehending the ever-changing competitive landscape in the region.

• Efficiently plan mergers and acquisitions, and partnership deals in the North America cartilage degeneration market by identifying segments with the most promising probable sales.

• Take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments.

• Obtain revenue forecast of market based on various segments for the period 2019–2027.